Skip Nav Destination
Issues
1 August 2006
-
Cover Image
Cover Image
The cover shows DES in complex with the human estrogen receptor α ligand binding domain. Shiau AK, Barstad D, Loria PM, Cheng L, Kushner PJ, Agard DA, Greene GL. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 1998;95:927–37. http://www.pdb.org/. - PDF Icon PDF LinkTable of Contents
ISSN 1055-9965
EISSN 1538-7755
Hypothesis/Commentary
Review
Research Articles
Associations of Ki-ras Proto-oncogene Mutation and p53 Gene Overexpression in Sporadic Colorectal Adenomas with Demographic and Clinicopathologic Characteristics
Janine G. Einspahr; Maria Elena Martinez; Ruiyun Jiang; Chiu-Hsieh Hsu; Achyut K. Bhattacharrya; Dennis J. Ahnen; Elizabeth T. Jacobs; P. Scott Houlihan; C. Renee Webb; David S. Alberts; Stanley R. Hamilton
Deletion Polymorphism of UDP-Glucuronosyltransferase 2B17 and Risk of Prostate Cancer in African American and Caucasian Men
Jong Park; Lan Chen; Luke Ratnashinge; Thomas A. Sellers; Jean-Paul Tanner; Ji-Hyun Lee; Nicole Dossett; Nicholas Lang; Fred F. Kadlubar; Christine B. Ambrosone; Babu Zachariah; Randy V. Heysek; Stephen Patterson; Julio Pow-Sang
Design and Progress of a Trial of Selenium to Prevent Prostate Cancer among Men with High-Grade Prostatic Intraepithelial Neoplasia
James R. Marshall; Wael Sakr; David Wood; Donna Berry; Catherine Tangen; Felicia Parker; Ian Thompson; Scott M. Lippman; Ronald Lieberman; David Alberts; David Jarrard; Charles Coltman; Peter Greenwald; Lori Minasian; E. David Crawford
Associations among Mammographic Density, Circulating Sex Hormones, and Polymorphisms in Sex Hormone Metabolism Genes in Postmenopausal Women
Ruth Warren; Jane Skinner; Evis Sala; Erika Denton; Mitch Dowsett; Elizabeth Folkerd; Catherine S. Healey; Alison Dunning; Deborah Doody; Bruce Ponder; Robert N. Luben; N.E. Day; Douglas Easton
The Prevalence of CDKN2A Germ-Line Mutations and Relative Risk for Cutaneous Malignant Melanoma: An International Population-Based Study
Marianne Berwick; Irene Orlow; Amanda J. Hummer; Bruce K. Armstrong; Anne Kricker; Loraine D. Marrett; Robert C. Millikan; Stephen B. Gruber; Hoda Anton-Culver; Roberto Zanetti; Richard P. Gallagher; Terence Dwyer; Timothy R. Rebbeck; Peter A. Kanetsky; Klaus Busam; Lynn From; Urvi Mujumdar; Homer Wilcox; Colin B. Begg; The GEM Study Group
Short Communications
Null Results in Brief
No Increased Risk of Breast Cancer Associated with Alcohol Consumption among Carriers of BRCA1 and BRCA2 Mutations Ages <50 Years
Valerie McGuire; Esther M. John; Anna Felberg; Robert W. Haile; Norman F. Boyd; Duncan C. Thomas; Mark A. Jenkins; Roger L. Milne; Mary B. Daly; John Ward; Mary Beth Terry; Irene L. Andrulis; Julia A. Knight; Andrew K. Godwin; Graham G. Giles; Melissa Southey; Dee W. West; John L. Hopper; Alice S. Whittemore; kConFab Investigators
Corrections
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.